Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200066918Phase 4Not yet recruiting
Phase 4, randomised trial of shenfu injection in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Incidence of major arrhythmias during hospitalization. Planned start Dec 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200066918.